数字单人操作胆道镜治疗活体供肝移植受者标准ERCP失败的困难吻合口胆管狭窄:SPYPASS-2研究(附视频)
这项前瞻性研究纳入40例活体供肝移植后吻合口胆管狭窄患者,在常规ERCP导丝置入困难(插管时间>10分钟)时采用单人操作胆道镜(SpyGlass DS II)辅助治疗。技术成功率为92.5%(37/40),临床成功率为82.5%(33/40),术后胆管炎、胰腺炎和出血发生率分别为10.0%、15.0%和2.5%,无肠穿孔,不良事件均为轻度。结论显示该方法在标准ERCP失败后对困难吻合口胆管狭窄有效且安全。
要点
- 标准ERCP失败的活体供肝移植后吻合口胆管狭窄,单人操作胆道镜辅助技术成功率达92.5%。
- 临床成功率为82.5%,术后胆管炎、胰腺炎、出血发生率分别为10.0%、15.0%、2.5%。
- 无肠穿孔发生,所有不良事件均为轻度;早期支架移位5.4%,1个月内再干预10.8%。
核心结论
- 本研究表明,在活体供肝移植患者标准ERCP失败后,单人操作胆道镜辅助管理困难吻合口胆管狭窄有效且安全。
研究设计与样本
- 前瞻性研究,纳入2021年10月至2023年5月期间40例活体供肝移植后吻合口胆管狭窄患者,在常规ERCP导丝跨越狭窄困难(插管时间>10分钟)时行单人操作胆道镜(SpyGlass DS II;Boston Scientific Corp, Natick, Mass, USA)辅助ERCP治疗。
- 主要终点为技术成功,定义为成功将导丝置入跨越吻合口胆管狭窄和/或后续治疗;次要终点为临床成功率、不良事件率和再干预率。
主要发现
- 患者平均年龄59.7 ± 7.2岁,活体供肝移植至吻合口胆管狭窄发生的平均时间为212 ± 230天。
- 技术成功率为92.5%(37/40),临床成功率为82.5%(33/40)。
- ERCP术后胆管炎、胰腺炎和出血发生率分别为10.0%、15.0%和2.5%。
- 未发生肠穿孔,所有不良事件均为轻度。
- 1个月内早期支架移位发生于2例患者(5.4%),4例患者(10.8%)在1个月内需要再干预。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Liver transplantation (LT) is a curative treatment for end-stage liver disease. Anastomotic biliary strictures (ABSs) are more common in living donor LT (LDLT). However, the success rate of ERCP for ABSs remains unsatisfactory. In this study, we evaluated the efficacy of single-operator cholangioscopy (SOC) for ABS treatment in LDLT recipients where standard ERCP failed to access the stricture. METHODS: This prospective study included 40 LDLT patients undergoing ERCP with SOC (SpyGlass DS II; Boston Scientific Corp, Natick, Mass, USA) to treat ABSs when guidewire placement across the ABS was difficult during conventional ERCP (cannulation time >10 minutes) between October 2021 and May 2023. Our primary endpoint was technical success, defined as successful guidewire placement across the ABS and/or subsequent treatment. Secondary endpoints were rates of clinical success, adverse events, and reintervention. RESULTS: The mean patient age was 59.7 ± 7.2 years, and the mean time from LDLT to the occurrence of ABS was 212 ± 230 days. Technical and clinical success were achieved in 92.5% (37/40) and 82.5% (33/40) of patients, respectively. The rates of post-ERCP cholangitis, pancreatitis, and bleeding were 10.0%, 15.0%, and 2.5%, respectively. Intestinal perforation did not occur, and all adverse events were mild in severity. Early stent migration within 1 month occurred in 2 patients (5.4%), and 4 patients (10.8%) required reintervention within 1 month. CONCLUSIONS: This study shows the efficacy and safety of SOC-facilitated management for difficult ABSs in LDLT patients after failure of standard ERCP. (Clinical trial registration number: NCT05065125.).
引用
- Cho IR, Lee SH, Kang J, et al. Digital single-operator cholangioscopy for difficult anastomotic biliary strictures in living donor liver transplant recipients after failure of standard ERCP: SPYPASS-2 study (with videos). Gastrointest Endosc. 2024. PMID: 39557203. doi:10.1016/j.gie.2024.11.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。